Medications: a risk factor for periodontal disease diagnosis and treatment.
Among the aging U.S. population, patients are taking significantly more medications than in the past. In view of this, dentists should take careful medical histories, including use of herbal agents, and be aware of medication-related problems and their potential effect on the diagnosis and treatment of periodontal disease. This review highlights major concerns about medications as a risk factor for periodontal therapy. Medications and their impact on periodontal disease can be categorized as those which affect oral hygiene, diagnosis, gingival and oral mucosa, and alveolar bone.
Ciancio
Sebastian G
SG
Department of Periodontics & Endodontics, School of Dental Medicine, University at Buffalo, Buffalo, NY 14214, USA. ciancio@buffalo.edu
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D016301:Alveolar Bone Loss / Q000139:chemically induced / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use; D004363:Drug Utilization; D064420:Drug-Related Side Effects and Adverse Reactions; D019214:Gingival Overgrowth / Q000139:chemically induced; D006801:Humans; D009061:Mouth Mucosa / Q000187:drug effects; D010510:Periodontal Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D010859:Pigmentation Disorders / Q000139:chemically induced; D019338:Polypharmacy; D012307:Risk Factors; D013752:Tetracycline / Q000009:adverse effects / Q000627:therapeutic use; D014987:Xerostomia / Q000139:chemically induced
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D050071:Bone Density Conservation Agents; D013752:Tetracycline